Life Sciences
Asia-Pacific Guide 2025 : Asia-Pacific Region
Band 2
Contact number
+852 3405 2300Chambers Review
Norton Rose Fulbright handles complex M&A mandates for global companies investing in Asia, particularly in the pharmaceuticals field, and offers a well-established IP practice especially on the patent protection front, as well as regulatory compliance matters throughout its Asia network. It also advises on issues relating to clinical trial agreements, compliance investigations research, licensing, research and collaboration arrangements. The firm is particularly well-placed to handle Australian or Chinese mandates – or deals spanning those jurisdictions.
Justin Davidson in Hong Kong and Bernard O'Shea in Melbourne are both key contacts.
Work Highlights
- Norton Rose Fulbright advised both GSK, and its spin-out Haleon, on trade mark prosecution issues and counterfeit matters, including the management of their trade mark portfolio and renewals in Hong Kong and Macau.
Strengths
Provided by Chambers
"The professionals at Norton Rose are very helpful and provide a high level of service."
"The professionals at Norton Rose are very helpful and provide a high level of service."